Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Jeryl Lynn Hilleman
Age : 63
Public asset : 1,122,256 USD
Linked companies : NovoCure Limited - SI-BONE, Inc. - HilleVax, Inc. - Minerva Neurosciences, Inc.
Summary 
Presently, Jeryl Lynn Hilleman is Chairman at Omada Health, Inc. Ms. Hilleman is also Member of Henry Crown Fellowship Program and Member of Aspen Global Leadership Network and on the board of 6 other companies.

Ms. Hilleman previously was Chief Financial Officer & Vice President-Finance at Geron Corp., Chief Financial Officer at Intersect ENT, Inc., Chief Financial Officer of Amyris, Inc., Chief Financial Officer & Executive Vice President for Symyx Technologies, Inc., CFO, Secretary, CAO & Head-Investor Relations at Ocera Therapeutics, Inc. and Chief Financial Officer & Vice President-Finance of Cytel Corp.

Jeryl Lynn Hilleman received an undergraduate degree from Brown University and an MBA from The Wharton School of the University of Pennsylvania.


Current positions of Jeryl Lynn Hilleman 
NameTitle Since
NovoCure Limited
(Medical Equipment, Supplies & Distribution)
Independent Director 2018
SI-BONE, Inc.
(Medical Equipment, Supplies & Distribution)
Independent Director 2019
HilleVax, Inc.
(Biotechnology & Medical Research)
Independent Director 2021
Minerva Neurosciences, Inc.
(Biotechnology & Medical Research)
Independent Director 2018
Omada Health, Inc. Chairman -
Cardiva Medical, Inc. Independent Director 2020
GeoHazards International Trustee -
Henry Crown Fellowship Program Member -
Aspen Global Leadership Network Member -


Holdings of Jeryl Lynn Hilleman 
NameEquities%Valuation
NovoCure Limited (NVCR)
(Medical Equipment, Supplies & Distribution)
6,7510.0065%469,195 USD
HilleVax, Inc. (HLVX)
(Biotechnology & Medical Research)
42,0250.13%459,333 USD
SI-BONE, Inc. (SIBN)
(Medical Equipment, Supplies & Distribution)
14,6450.043%193,314 USD
Minerva Neurosciences, Inc. (NERV)
(Biotechnology & Medical Research)
1250.0023%414 USD
Talis Biomedical Corporation (TLIS)
(Biotechnology & Medical Research)
00.0000%0 USD


Jeryl Lynn Hilleman: Personal Network 
Most Read News 
07/29MARK ZUCKERBERG : Company's pandemic-era forecast was too rosy
RE
07/29CATHIE WOOD : Wood's ARK fund on track for first monthly gain since Oct as risky stocks rally
RE
08/06ELON MUSK : Musk says Twitter deal should go ahead if it provides proof of real accounts
RE
08/09ELON MUSK : Elon Musk sells 7.92 million Tesla shares worth $6.9 billion - SEC filing
RE
08/04JACK DORSEY : Dorsey-led Block posts loss for second quarter
RE
08/02ELON MUSK : Twitter queries banks on Musk's attempts to undermine $44 billion deal
RE
05:51aMASAYOSHI SON : With Alibaba stake cut, SoftBank's Son cools toward China tech
RE
08/01DAVID EINHORN : Einhorn's Greenlight takes stake in Twitter - letter
RE
08/02STEPHEN KING : Horror author Stephen King says in publishing trial that consolidation hurts competition
RE
08/01STEPHEN KING : Stephen King goes to bat for U.S. gov't in case against book publishing mega-merger
RE
More news


© 2022 People and Ownership :   
Jeryl Lynn Hilleman : Connections